ANDA 70347, held by Par Pharmaceutical. Amiloride Hydrochloride; Hydrochlorothiazide.
As of Nov 22, 2026, ANDA 70347 (Hydro-Ride), held by Par Pharmaceutical, was first approved by FDA on Aug 6, 1986, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 6, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydro-RideEQ 5MG ANHYDROUS;50MG · tablet;oral | Amiloride Hydrochloride; Hydrochlorothiazide | Discontinued |
| May 13, 1996 | Supplement 12Labeling | Approved | None posted |
| May 13, 1996 | Supplement 11Manufacturing | Approved | None posted |
| Apr 24, 1996 | Supplement 10Labeling | Approved | None posted |
| Mar 28, 1995 | Supplement 9Labeling | Approved | None posted |
| Jan 5, 1995 | Supplement 8Labeling | Approved | None posted |
| Sep 10, 1992 | Supplement 7Labeling | Approved | None posted |
| Oct 27, 1987 | Supplement 5Manufacturing | Approved | None posted |
| Oct 27, 1987 | Supplement 4Manufacturing | Approved | None posted |
| Aug 6, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters